| Literature DB >> 11031210 |
S Toshima1, A Hasegawa, M Kurabayashi, H Itabe, T Takano, J Sugano, K Shimamura, J Kimura, I Michishita, T Suzuki, R Nagai.
Abstract
Recent studies have established oxidative modification of low density lipoprotein (LDL) as an important atherogenic factor. We examined the clinical relevance of circulating oxidized LDL (OxLDL) levels in atherosclerotic disease by an enzyme immunoassay with use of specific antibodies against OxLDL (FOH1a/DLH3) and apolipoprotein B. Plasma OxLDL levels were significantly higher in patients with coronary heart disease (n=65) than in control subjects (n=181; 201. 3+/-11.2 versus 112.4+/-3.3 U/dL, respectively; P<0.01). OxLDL levels were not associated with age, sex, total cholesterol, or apolipoprotein B levels in normal control subjects. Our results suggest that circulating OxLDL may be a possible biochemical risk marker for coronary heart disease.Entities:
Mesh：
Substances：
Year: 2000 PMID： 11031210 DOI： 10.1161/01.atv.20.10.2243
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN： 1079-5642 Impact factor: 8.311